期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | mBio LetPub Score 8.0
52 ratings
Rate
Reputation 8.5 Influence 7.5 Speed 9.3 | ||||||||||||||||||||
期刊簡稱 | MBIO | ||||||||||||||||||||
ISSN | 2150-7511 | ||||||||||||||||||||
h-index | 87 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 3.90%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://mbio.asm.org/ | ||||||||||||||||||||
在線稿件提交 | http://mbio.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | American Society for Microbiology | ||||||||||||||||||||
主題領域 | MICROBIOLOGY | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 2010 | ||||||||||||||||||||
每年文章數 | 728每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 68.33% | ||||||||||||||||||||
OA Related Info | APC: Yes( USD3900; ) APC waiver:Check Notes Other charges: Check Notes Keywords: microbiology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2150-7511%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 下一頁 末頁 (頁 | |
[mBio] 的評論 | 撰寫評論 |
作者: 东风富贵 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 19:08:21 評論於 It has been 19 days since I submitted my manuscript, and it is still with the editor. I am so worried(0) 讚! | 东风富贵 |
作者: 东风富贵 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 18:30:01 評論於 Good luck(0) 讚! | 东风富贵 |
作者: 珉林天春 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-21 17:14:12 評論於 Submitted 15 days ago, still with editor. It's really frustrating, no news yet(0) 讚! | 珉林天春 |
作者: 珉林天春 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-21 14:33:39 評論於 Are they still on vacation?(0) 讚! | 珉林天春 |
作者: 珉林天春 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-13 19:56:33 評論於 Submitted 7 days ago, still with editor(0) 讚! | 珉林天春 |
作者: QQQQQQ 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2024-04-15 15:02:42 評論於 Please check the email address of the corresponding author. If the co-authors are not receiving these emails, it may be because there is a missing word in the copyright agreement(0) 讚! | QQQQQQ |
作者: 削月泰平 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-12 13:11:00 評論於 Please translate the following passage into English(0) 讚! | 削月泰平 |
作者: 嘀哩哩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-02 15:37:10 評論於 Can I ask what to do if the message "waiting for author approval of converted files" appears after submitting an article to the magazine? Will the corresponding author receive an email?(0) 讚! | 嘀哩哩 |
作者: 嘀哩哩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-02 15:30:02 評論於 Could you please advise on what to do if the message "Waiting for Author Approval of Converted Files" appears after submitting an article to this magazine? Will the corresponding author receive an email notification? I have submitted twice and encountered the same situation both times, and I am at a loss on how to proceed(0) 讚! | 嘀哩哩 |
作者: 首龚 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-03-29 10:57:19 評論於 mbio is the flagship of ASM, while microbiome is BMC's. Of course, the former has a better reputation. The latter has a high impact factor because it mainly publishes hot topics like gut microbiota and other popular pseudoscience(0) 讚! | 首龚 |
作者: pubpubCNS 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-08 16:45:07 評論於 After my brother, did you receive it?(0) 讚! | pubpubCNS |
作者: 德云小生 領域: 生物学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-12-23 20:38:29 評論於 Zheng XX, the scum of the academic community! Reviewing so many papers in a year, everyone should think about it carefully! Can only laugh!(0) 讚! | 德云小生 |
作者: 德云小生 領域: 生物学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-12-23 20:34:58 評論於 Zheng XX, a disgrace in the academic community! He parades as a top scientist and goes on tours across the country all day long! This person is quite bizarre! Please take a closer look at the many articles he reviews in a year. It's just laughable!(89) 讚! | 德云小生 |
作者: 四风香山 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-19 08:43:35 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Research focus: Virology sharing experience: Finally got a top in Zone 1, sharing the timeline: submitted on 3.13, with editor on the same day, under review on 3.20, with editor on 4.12, rejected on the same day, encouraged to resubmit and conduct additional experiments, dragging on for more than half a year, European efficiency haha, resubmitted on 12.7, directly accepted on 12.15(0) 讚! | 四风香山 |
作者: 平原冬莲 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-29 19:54:35 評論於 If it's in the direction of microbial ecology, give Microbiome a try first; if it's in the molecular or non-physiological direction, mBio is the first choice(0) 讚! | 平原冬莲 |
作者: 凌霄以儿 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-16 23:31:39 評論於 Research focus: Microbial experience sharing: Which is better, Mbio or microbiome? If submitting a paper on environmental microbiology, which journal should be considered first?(0) 讚! | 凌霄以儿 |
作者: 璃月雨石 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-20 18:27:38 評論於 Do we need to write a response letter to the reviewer for resubmission?(0) 讚! | 璃月雨石 |
作者: 璃月雨石 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-20 08:29:11 評論於 Do we need to write a response letter to the reviewer for resubmission?(0) 讚! | 璃月雨石 |
作者: 水月若枫 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-04 19:28:22 評論於 Regarding the investment(0) 讚! | 水月若枫 |
作者: David zhou 領域: 生物学 審稿時間: 3.0 month(s) 結果: 直接被接受 撰寫評論 |
2023-02-04 17:14:11 評論於 Good magazine. High-quality research rejected by PLOS can try MBio. Our laboratory has two cases of PLOS rejection published in MBio.(34) 讚! | David zhou |
作者: 安迪.孟菲斯 領域: 生物学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-12-21 20:03:48 評論於 I have the same experience as you... but I am not the first author, just a co-author. PLOS is indeed a bit more difficult.(0) 讚! | 安迪.孟菲斯 |
作者: 安迪.孟菲斯 領域: 生物学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-12-21 20:02:14 評論於 "Plos pathogens and mBio are indeed often regarded as articles of the same level. We cannot submit to Plos pathogens in our field. In terms of article quality, Plos pathogens is indeed more solid!"(54) 讚! | 安迪.孟菲斯 |
作者: song 領域: 生物学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-12-19 09:40:37 評論於 This person is quite crazy. I looked up his resume and he has been bragging about his success all the way.(0) 讚! | song |
作者: song 領域: 生物学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-12-19 09:39:44 評論於 Agree. Both Mibio and PLOS Pathogens are good. They are often compared. But if I have to choose one, I would still choose PLOS. I often hear about cases where papers rejected by PLOS are published in Mibio. But I haven't seen any successful cases of the reverse happening.(0) 讚! | song |
作者: 无影东帅 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-18 14:46:33 評論於 Research Focus: Innate Immunity Sharing Experience: Submitting with Editor Is it necessary to reject the submission on Friday if it coincidentally falls on a Saturday?(0) 讚! | 无影东帅 |
首頁 上一頁 1 2 3 4 5 6 下一頁 末頁 (頁 |
Contact us